ScripGSK will have to wait three months longer for the US Food and Drug Administration to make a ruling on its myelofibrosis candidate momelotinib, with the agency pushing back its decision date to 16 Sep
Pink SheetPfizer Inc. has laid the groundwork to continue its reign as the biggest of the big pharma companies with the industry’s largest array of new drug and biologic applications for US FDA approval. Seven
ScripSwedish Orphan Biovitrum AB (Sobi) said on 10 May that it will pay $1.7bn to acquire CTI BioPharma Corp. , buying an immediate source of revenue growth in the form of CTI’s Vonjo (pacritinib), appro
ScripIncyte Corporation ’s efforts to maintain Jakafi’s (ruxolitinib) place in the market before its exclusivity runs out hit a snag with the announcement that it stopped a combination trial of the drug in